NCT05340868View on ClinicalTrials.gov

Genetics of the Acute Response to Oral Semaglutide

NARecruitingINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
PreDiabetesPrediabetic StateObesity
Interventions
DRUG

Semaglutide Pill

Oral semaglutide treatment

Trial Locations (1)

15-276

RECRUITING

Clinical Research Centre, Medical University of Bialystok, Bialystok

All Listed Sponsors
lead

Medical University of Bialystok

OTHER